RevGel-seq: instrument-free single-cell RNA sequencing using a reversible hydrogel for cell-specific barcoding.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
24 03 2023
Historique:
received: 13 10 2022
accepted: 20 03 2023
medline: 28 3 2023
entrez: 25 3 2023
pubmed: 26 3 2023
Statut: epublish

Résumé

Progress in sample preparation for scRNA-seq is reported based on RevGel-seq, a reversible-hydrogel technology optimized for samples of fresh cells. Complexes of one cell paired with one barcoded bead are stabilized by a chemical linker and dispersed in a hydrogel in the liquid state. Upon gelation on ice the complexes are immobilized and physically separated without requiring nanowells or droplets. Cell lysis is triggered by detergent diffusion, and RNA molecules are captured on the adjacent barcoded beads for further processing with reverse transcription and preparation for cDNA sequencing. As a proof of concept, analysis of PBMC using RevGel-seq achieves results similar to microfluidic-based technologies when using the same original sample and the same data analysis software. In addition, a clinically relevant application of RevGel-seq is presented for pancreatic islet cells. Furthermore, characterizations carried out on cardiomyocytes demonstrate that the hydrogel technology readily accommodates very large cells. Standard analyses are in the 10,000-input cell range with the current gelation device, in order to satisfy common requirements for single-cell research. A convenient stopping point after two hours has been established by freezing at the cell lysis step, with full preservation of gene expression profiles. Overall, our results show that RevGel-seq represents an accessible and efficient instrument-free alternative, enabling flexibility in terms of experimental design and timing of sample processing, while providing broad coverage of cell types.

Identifiants

pubmed: 36964177
doi: 10.1038/s41598-023-31915-y
pii: 10.1038/s41598-023-31915-y
pmc: PMC10039079
doi:

Substances chimiques

Hydrogels 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4866

Informations de copyright

© 2023. The Author(s).

Références

Nat Methods. 2022 Jan;19(1):41-50
pubmed: 34949812
Cell. 2015 May 21;161(5):1202-1214
pubmed: 26000488
Front Genet. 2023 Jan 04;13:1100016
pubmed: 36685871
Am J Physiol Gastrointest Liver Physiol. 2021 Apr 1;320(4):G439-G449
pubmed: 33501884
Nat Biotechnol. 2020 Jun;38(6):747-755
pubmed: 32518403
Semin Immunopathol. 2023 Jan;45(1):71-89
pubmed: 36414692
Nat Biotechnol. 2020 Jun;38(6):737-746
pubmed: 32341560
Cancer Cell. 2021 Aug 9;39(8):1062-1080
pubmed: 34329587
Cell Rep. 2019 Feb 5;26(6):1627-1640.e7
pubmed: 30726743
Nature. 2021 Sep;597(7875):196-205
pubmed: 34497388
Nat Methods. 2017 Apr;14(4):395-398
pubmed: 28192419
Nat Immunol. 2019 Feb;20(2):163-172
pubmed: 30643263
Nat Biotechnol. 2023 Mar 6;:
pubmed: 36879006
Nat Rev Genet. 2022 Dec;23(12):741-759
pubmed: 35859028
Lab Chip. 2017 Jul 25;17(15):2540-2541
pubmed: 28721415
Nature. 2022 Dec;612(7940):577-579
pubmed: 36513832
Bioessays. 2022 Nov;44(11):e2200084
pubmed: 36068142
Curr Opin Cell Biol. 2022 Jun;76:102101
pubmed: 35609365
Nature. 2020 May;581(7808):303-309
pubmed: 32214235
J Hematol Oncol. 2022 May 12;15(1):59
pubmed: 35549970
Cell Syst. 2016 Oct 26;3(4):346-360.e4
pubmed: 27667365
Nucleic Acids Res. 2023 Jan 6;51(D1):D924-D932
pubmed: 36189903
Science. 2018 Apr 13;360(6385):176-182
pubmed: 29545511
J Cell Mol Med. 2022 Sep;26(17):4645-4657
pubmed: 35906816
Int J Mol Sci. 2021 Jan 09;22(2):
pubmed: 33435513
Front Genet. 2022 Oct 03;13:994069
pubmed: 36263428
Genome Biol. 2020 Feb 7;21(1):31
pubmed: 32033589
Adv Exp Med Biol. 2022;1361:269-282
pubmed: 35230694
Plant Sci. 2022 Dec;325:111486
pubmed: 36202294
Genes (Basel). 2023 Jan 04;14(1):
pubmed: 36672883
Nat Commun. 2017 Jan 16;8:14049
pubmed: 28091601
Trends Genet. 2021 Dec;37(12):1064-1068
pubmed: 34462156
Ann N Y Acad Sci. 2021 Dec;1506(1):74-97
pubmed: 34605044

Auteurs

Jun Komatsu (J)

Scipio Bioscience, Paris, France.

Alba Cico (A)

Scipio Bioscience, Paris, France.

Raya Poncin (R)

Scipio Bioscience, Paris, France.

Maël Le Bohec (M)

Scipio Bioscience, Paris, France.

Jörg Morf (J)

Scipio Bioscience, Paris, France.
Skyhawk Therapeutics, Basel, Switzerland.

Stanislav Lipin (S)

Scipio Bioscience, Paris, France.

Antoine Graindorge (A)

Scipio Bioscience, Paris, France.

Hélène Eckert (H)

Scipio Bioscience, Paris, France.

Azadeh Saffarian (A)

Scipio Bioscience, Paris, France.

Léa Cathaly (L)

Scipio Bioscience, Paris, France.

Frédéric Guérin (F)

Scipio Bioscience, Paris, France.

Sara Majello (S)

Scipio Bioscience, Paris, France.

Damien Ulveling (D)

Scipio Bioscience, Paris, France.

Anaïs Vayaboury (A)

Scipio Bioscience, Paris, France.

Nicolas Fernandez (N)

Scipio Bioscience, Paris, France.

Dilyana Dimitrova (D)

Scipio Bioscience, Paris, France.

Xavier Bussell (X)

Scipio Bioscience, Paris, France.

Yannick Fourne (Y)

Scipio Bioscience, Paris, France.

Pierre Chaumat (P)

Scipio Bioscience, Paris, France.

Barbara André (B)

Scipio Bioscience, Paris, France.

Elodie Baldivia (E)

Scipio Bioscience, Paris, France.

Ulysse Godet (U)

Scipio Bioscience, Paris, France.

Mathieu Guinin (M)

Scipio Bioscience, Paris, France.

Vivien Moretto (V)

Scipio Bioscience, Paris, France.

Joy Ismail (J)

Scipio Bioscience, Paris, France.

Olivier Caille (O)

Scipio Bioscience, Paris, France.

Natacha Roblot (N)

Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, 75012, Paris, France.

Carine Beaupère (C)

Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, 75012, Paris, France.

Alexandrine Liboz (A)

Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, 75012, Paris, France.

Ghislaine Guillemain (G)

Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, 75012, Paris, France.

Bertrand Blondeau (B)

Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, 75012, Paris, France.

Pierre Walrafen (P)

Scipio Bioscience, Paris, France. pierre.walrafen@scipio.bio.

Stuart Edelstein (S)

Scipio Bioscience, Paris, France. stuart.edelstein@scipio.bio.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH